Doylestown Health is consistent with the COVID-19 recommendations of the Centers for Disease Control (CDC)

Doylestown Health supports continued proactive efforts to prevent an uncontrolled outbreak among our most vulnerable populations, including unvaccinated adults as well as children who are ineligible for vaccination at this time.

For more Doylestown Health COVID-19 information, visit our COVID-19 Update page.

Howard S. Zipin, MD

Howard S. Zipin, MD

Hematology-Oncology, Medical Oncology, Oncology, Hematology

Clinical Services

Cancer

Certifications

Medical Oncology, Hematology (Internal Medicine), Internal Medicine

Education

Medical School: Temple University

Residency: Temple University Hospital

Fellowship: Fox Chase Cancer Center

Gender

Male

Language

English

Awards and Accolades

Howard S. Zipin, MD, has been recognized by Philadelphia Magazine as a Top Doc for 2018-2020.